Director, US HEOR Strategy Lead - Rheumatology; RA, GCA, and SLE

Company Description

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

Leads the development & execution of HEOR strategy and initiatives for multiple on-market and/or pipeline development assets. Is the brand/asset leader representing HEOR on cross functional teams and in the pipeline commercialization teams. Accountable for HEOR strategies and execution, looks to shape brand/asset/enterprise strategies by bringing in expertise and experience within and beyond his/her subject matter expertise. Ensures project plans across all products within their TA portfolio integrates and aligns with the product strategy plans from matrix groups as well as commercial interests and scientific integrity of studies.

W/a view across TA assets, ensures there is no overlap of projects and leverages endeavors across the TA; provides updates on execution of plans to products as well as functional management. In the development of product strategic plans, liaises with other members of the product team to generate innovative ideas and get buy‑in to strategies.

• Oversees the design and conduct of multiple programs as well as effectively communicates the findings and strategic impact of findings to internal (Executive Leadership, Area VPs, GMs etc.) and external (e.g., HTAs/Payors, patient (advocacy groups) and KOLs etc.) audiences
• HEOR strategy lead interacting with cross‑functional brand teams
• Determine, in collaboration with cross functional leaders, the global development strategy for new or marketed products and contribute to the Therapeutic Area Long Range Plan and Portfolio Planning
• Drives the design and aggressive execution of a high quality HEOR program supporting the therapeutic area strategy for pipeline products as well as on‑market products that effectively and efficiently meets ethical, scientific, regulatory, commercial, and quality requirements
• In the post‑marketing setting, this position is responsible for developing and executing product life‑cycle and labeling strategies in collaboration with scientific and commercial team members across the TA portfolio. He/she is responsible for the scientific and communication excellence of all data elements agreed to by the matrix team
• Accountable for end‑to‑end delivery of HEOR book of work under their remit, from strategy development to content pull‑through
• Accountable to ensuring strong partnership with all relevant HEOR COE functions to ensure a comprehensive HEOR voice is represented in cross‑functional meetings
• Executive presence and ability to engage with senior leaders in a cross functional setting

• Advanced degree, MD, Pharm
  
  D, MS in Economics, Econometrics, or (pharmaco) epidemiology
• Minimum of ten years working experience with Master’s, seven years with PhD/Pharm
  
  D can include fellowship experience). Professional training in a health field (MD, Pharm
  
  D, etc.) is a plus
• Experience leading complex products and/or clinical development in support of pipeline development and on‑market product support. Experience with in pharmaceutical industry preferred
• Must perform at times in previously uncharted territory with few, if any, established guidelines or procedures. At other times, exceedingly complex governmental rules and regulations must be followed. For problems surrounded by complex rules and regulations, the Director must be able to direct compliance knowledgeably and expeditiously
• Must be able to develop creative and effective solutions to inter‑ and intra‑project priority conflicts, resource constraints and other problems which may impact project or group goals and deliverables across multiple programs
• Extensive knowledge of the global regulatory, HTA and PR&A landscape, as…